MedTech SuperConnector
Translating Research into Healthcare Solutions
The MTSC is connecting academia, industry, and investment capital to turn MedTech ideas into commercial realities.
Funded by Research England, the MedTech SuperConnector is an Imperial College-led initiative from a consortium of eight dynamic London universities with interest in nurturing talent, ideas, and entrepreneurship. MTSC focuses uniquely on a new route for early career researchers (ECRs) and graduate students to translate MedTech discoveries from academic labs into startup companies, proposing new solutions to today’s health challenges.
Four cohorts of ECRs are being taken through an eight-month entrepreneurial training programme. In addition to expert business mentoring and training, they have funding and access to state-of-the-art facilities and expertise across the eight institutions. Through the SuperConnector they also have the opportunity to create connections with industry partners and potential investors to bring their projects to market.
Following a competitive call for applicants, the first cohort of 10 innovators included two CPS ECRs. Letizia Gionfrida used artificial intelligence and motion analysis to improve the diagnosis of musculoskeletal disorders, and George Waddell developed an online platform to enhance clinical communication training. A full list of projects can be found on the MedTech SuperConnector website.
CPS team
Aaron Williamon, RCM (PI)
Terry Clark, RCM
Letizia Gionfrida, RCM
George Waddell, RCM
For the full project team,
visit the MedTech SuperConnector website.
Partners
Bucks New University
Francis Crick Institute
Imperial College London
Institute of Cancer Research
Queen Mary University of London
Royal College of Art
Royal Veterinary College
Supported by
Research England
(2018-21)
Learn more
Visit the MedTech SuperConnector website.